Psoriasis is a chronic immune-mediated disease that presents with inflamed plaques covered by silvery scales. Treatment depends on severity and impact on quality of life.
If less than 3–5% of total body surface area is involved, over-the-counter topical agents can play a role in management.
First-line recommendation for mild disease:
Topical corticosteroids: reduce inflammation and plaque formation in mild cases. Dose: 1% hydrocortisone may be used during disease flares until skin lesions improve, or as maintenance therapy for patients with frequent, recurrent flares at the same site. Hydrocortisone 1% psoriasis lotion (FDA M017).
Keratinolytics: Salicylic acid 2% cream (FDA M006) and coal tar products can be used to reduce scaling. Topical tazarotene may be more clinically effective but is available only by prescription.
Prescription medications:
Higher strength topical corticosteroids: medium-potency (e.g., triamcinolone 0.1%) or high-potency (e.g., fluocinonide 0.05%)
Systemic agents (e.g., methotrexate, cyclosporine): For widespread or resistant disease.
Biologic agents (e.g., TNF inhibitors, IL-17 inhibitors): For moderate-to-severe cases.
Citations:
Armstrong, A. W., & Read, C. (2020). Pathophysiology, clinical presentation, and treatment of psoriasis: a review. Jama, 323(19), 1945-1960.